Motesanib diphosphate
Showing 1 - 25 of 132
MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Adelaide, Australia
- +11 more
Oct 13, 2022
Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))
Recruiting
- Myelofibrosis
- Imetelstat
- Best Available Therapy (BAT)
-
La Jolla, California
- +165 more
Aug 19, 2022
Platelet Aggregation in COVID-19 Patients
Completed
- COVID-19
- blood sample for platelet aggregation
-
Mansoura, EgyptFaculty of Medicine
Oct 20, 2023
Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)
Recruiting
- Breast Cancer
- Talazoparib
- Sacituzumab Govitecan
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Substance Use Disorders Trial in Seoul (CDP-choline, Placebo, Supportive psychotherapy)
Recruiting
- Substance Use Disorders
- CDP-choline
- +2 more
-
Seoul, Korea, Republic ofEwha Womans University Mokdong Hospital
Jul 28, 2022
Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)
Completed
- Immune System Disorder (Healthy Volunteers)
- Belumosudil
- +3 more
-
Miami, FloridaInvestigational Site Number: 8400001
Apr 11, 2023
HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)
Recruiting
- HIV Infections
- co-formulated 25mg TAF/ 200mg FTC
-
Thika, KenyaKenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023
Therapeutic Adherence and Compliance Trial in New York, Cape Town (Feedback on DBS Concentrations)
Completed
- Therapeutic Adherence and Compliance
- Feedback on DBS Concentrations
-
New York, New York
- +1 more
Dec 27, 2022
Acute Coronary Syndrome Trial in Germany, Luxembourg (Blood sampling and analysis)
Terminated
- Acute Coronary Syndrome
- Blood sampling and analysis
-
Essen, Germany
- +3 more
Jan 21, 2022
Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)
Terminated
- Solid Tumor
- +6 more
-
Birmingham, Alabama
- +8 more
Feb 16, 2022
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Bespoke ctDNA Assay for Recurrence and Treatment Response
Recruiting
- Ovarian Cancer
- platinum-sensitive EOC
- platinum-resistant and rEOC
-
Shanghai, Shanghai, ChinaHao Wen
Jul 5, 2022
Acute Bacterial Skin and Skin Structure Infection Trial in Atlanta (Oritavancin)
Not yet recruiting
- Acute Bacterial Skin and Skin Structure Infection
-
Atlanta, GeorgiaMorehouse School of Medicine
Jan 13, 2023
Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200
Recruiting
- Drug Interaction
- Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Apr 21, 2022
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
HIV Trial in Roma (Antiviral Agents)
Not yet recruiting
- HIV Infections
- Antiviral Agents
-
Roma, ItalyFondazione PoliclinicoAgostino Gemelli IRCCS
Feb 9, 2023
HIV Prevention Trial in Los Angeles, Baltimore, Pittsburgh (Tenofovir enema, Saline enema)
Completed
- HIV Prevention
- Tenofovir enema
- Saline enema
-
Los Angeles, California
- +2 more
Jan 4, 2022
Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)
Active, not recruiting
- Ovarian Neoplasms
- Niraparib
- Bevacizumab
-
Mobile, Alabama
- +27 more
Nov 23, 2022